3,4,5-substituted pipeidine compounds

Details for Australian Patent Application No. 2006222232 (hide)

Owner Novartis AG

Inventors Konishi, Kazuhide; Ehara, Takeru; Irie, Osamu; Masuya, Keiichi; Kanazawa, Takanori; Suzuki, Masaki; Yokokawa, Fumiaki; Toyao, Atsushi; Nihonyanagi, Atsuko

Agent Davies Collison Cave

Pub. Number AU-A-2006222232

PCT Pub. Number WO2006/094763

Priority 0504850.9 09.03.05 GB

Filing date 7 March 2006

Wipo publication date 14 September 2006

International Classifications

C07D 211/60 (2006.01) Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings

A61K 31/4545 (2006.01)

A61P 9/00 (2006.01) Drugs for disorders of the cardiovascular system

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 413/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

Event Publications

27 September 2007 PCT application entered the National Phase

  PCT publication WO2006/094763 Priority application(s): WO2006/094763

18 November 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006222233-Formulation for aviptadil

2006222225-Varicella zoster virus vaccine